www.fdanews.com/articles/61605-neurologix-signs-pact-with-diamyd-subsidiary-on-parkinson-s-therapy
NEUROLOGIX SIGNS PACT WITH DIAMYD SUBSIDIARY ON PARKINSON'S THERAPY
August 10, 2006
Neurologix, Inc.,
a biotech company committed to developing innovative gene therapies for the brain
and central nervous systems, has entered into a licensing agreement with a subsidiary
of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh,
PA.
Pharmabiz